G/LIC/N/2/PHL/140  
 
25 February 2021  
(21-1657) Page: 1/33 
Committee on Import Licensing  Original: English  
 
AGREEMENT ON IMPORT LICENSING PROCEDURES  
NOTIFICATION UNDER ARTICLE 5.1 TO 5.4 OF THE AGREEMENT1 
PHILIPPINES  
The following notification dated 17 February 2021 , is being circulated at the request of the delegation 
of the Phillippines . 
 
TABLE OF CONTENTS  
 
 BOARD REGULATION NO.9, SERIES OF 2003  ................................ ...............................  2 
 BOARD REGULATION NO.3, SERIES OF 2005  ................................ ...............................  4 
 BOARD REGULATION NO.4, SERIES OF 2005  ................................ ...............................  6 
 BOARD REGULATION NO.5, SERIES OF 2005  ................................ ...............................  8 
 BOARD REGULATION NO.1, SERIES OF 2008  ................................ .............................  10 
 BOARD REGULATION NO.2, SERIES OF 2008  ................................ .............................  12 
 BOARD REGULATION NO.5, SERIES OF 2009  ................................ .............................  14 
 BOARD REGULATION NO.1, SERIES OF 2010  ................................ .............................  16 
 BOARD REGULATION NO.2, SERIES OF 2013  ................................ .............................  18 
 BOARD REGULATION NO.5, SERIES OF 2016  ................................ ...........................  20 
 BOARD REGULATION NO.6, SERIES OF 2016  ................................ ...........................  22 
 BOARD REGULATION NO.7, SERIES OF 2016  ................................ ...........................  24 
 BOARD REGULATION NO.8, SERIES OF 2016  ................................ ...........................  26 
 BOARD REGULATION NO.9, SERIES OF 2016  ................................ ...........................  28 
 BOARD REGULATION NO.10, SERIES OF 2016  ................................ .........................  30 
 BOARD REGULATION NO.11, SERIES OF 2016  ................................ .........................  32 
 
 
  
 
1 It is understood that the notifying Member has also completed its notification obligations under 
Article  1.4(a) and Article 8.2(b) regarding the relevant law/regulation/procedure notified for by filling this form 
in a full and complete manner.  G/LIC/ N/2/PHL/140  
 
- 2 - 
 
  
BOARD REGULATION NO.9, SERIES OF 2003  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new legislation/  
procedure  Board Regulation  No. 9, Series of 2003  – Adopting a nd Enforcing All 
Previously Issued  Dangerous Drugs  Board Resolutions/Regulations a nd 
Other Issuances that a re not inconsistent with the Provisions of RA 9165 
otherwise known as t he Comprehensive  Dangerous Drugs Act o f 2002  
3 Date of Publication  24 October 2003 
4 Date of entry into force  8 November 2003 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2003/Bd.%20Reg.%
209%2003.pdf   
6 Have you attached a copy of 
the regulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 
to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________ ; (please answer question 15 and 
16) 
8 List of products subject to 
licensing  Dangerous drugs and controlled precursors and essential chemicals  
 
9 Nature of licensing  Automatic:  [  ] 
 
Non-Automatic: [X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and the 
prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications  Ministr y/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph   
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman,  Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
 
2 "New licensing regulation/procedure" is understood to refer to any newly introduced law, regulation or 
procedure, and those wh ich are in force but being notified for the first time to the Committee . G/LIC/ N/2/PHL/140  
 
- 3 - 
 
   Category  Notification details  
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 4 - 
 
  
BOARD REGULATION NO.3, SERIES OF 2005  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new legislation/  
procedure  Board Regulation No. 3 , Series o f 2005  - Inclusion of Ketamine in the List 
of Dangerous  Drugs and Amending Sec. 32 -6(B) o f Board  Regulation No. 
3, Series of  2003 and in the List o f Dangerous Drugs to be Prescribed in 
a Single  Applicable Pr escription by a  Licensed Practitioner  
3 Date of Publication  19 July 2005 
4 Date of entry into force  3 August 2005 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2005/Bd.%20Reg.%
203%2005.pdf  
 
6 Have you attached a 
copy of the regulation 
(PDF) to the Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 
to 14)   
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 and 
16) 
8 List of products subject 
to licensing  Any material,  compound, mixture or preparation which contains any 
quantity of K etamine , including  its salts, isomers, and salts of isomers 
within the specific chemical designation, by  whatever official, common or 
unusual or brand name or designation is classified as a  dangerous drug.  
9 Nature of licensing  Automatic: [   ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for submission of 
applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman,  Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), 
please indicate the type 
of new change(s)  (a)  Termination  
(b)  Suspension  G/LIC/ N/2/PHL/140  
 
- 5 - 
 
   Category  Notification details  
(c)  Modification of specific details in existing  
procedures:  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one 
of the WTO official 
languages)   
 
  G/LIC/ N/2/PHL/140  
 
- 6 - 
 
  
BOARD REGULATION NO.4, SERIES OF 2005  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new legislation/  
procedure  Board Regulation No. 4 , Series o f 2005  - Reclassifying Ephedrine a nd 
Pseudoephedrine  as Dangerous Drugs  
3 Date of Publication  19 July 2005 
4 Date of entry into force  3 August 2005 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2005/Bd.%20Reg.%
204%2005.pdf   
6 Have you attached a 
copy of the regulation 
(PDF) to the Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 
to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 and 
16) 
8 List of products subject 
to licensing  All raw materials of Ephedrine and Pseudoephedrine of  any of their salts, 
as well as preparations containing any of the said drugs are hereby  
reclassified as dangerous drugs .  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative purpose/  
measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for submission of 
applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), 
please indicate the type 
of new change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 7 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one 
of the WTO official 
languages)   
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 8 - 
 
  
BOARD REGULATION NO.5, SERIES OF 2005  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new legislation/  
procedure  Board Regulation No. 5 , Series o f 2005  - Inclusion o f Thionyl Chlor ide in 
the List o f Controlled Prec ursors and Essential Chemicals  
3 Date of Publication  19 July 2005 
4 Date of entry into force  3 August 2005 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2005/Bd.%20Reg.%2
05%2005.pdf  
 
6 Have you attached a copy 
of the regulation (PDF) to 
the Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 to 
14) 
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________ ;  ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  All raw material  and preparations/mixtures containing Thionyl Chloride  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and the 
prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for 
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  
 Product coverage;  G/LIC/ N/2/PHL/140  
 
- 9 - 
 
   Category  Notification details  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official 
languages)   
 
 
  G/LIC/ N/2/PHL/140  
 
- 10 - 
 
  
BOARD REGULATION NO.1, SERIES OF 2008  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 1 , Series of 2008  - Inclusion o f Oripavine in the List 
of Dangerous Drugs  
3 Date of Publication  14 May 2008 
4 Date of entry into force  29 May 2008 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2008/Bd.%20Reg.%2
01%2008.pdf  
 
6 Have you attached a copy 
of the regulation (PDF) to 
the Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 to 
14) 
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 and 
16) 
8 List of products subject to 
licensing  Oripavine  and any material, compound, mixture or  preparation which 
contains any quantity of O ripavine , including its salts, isomers, and  salts of 
isomers within the specific chemical designation, by whatever official, 
common,  unusua l or brand name or designation  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and the 
prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for submission of 
applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 11 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one 
of the WTO official 
languages)   
 
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 12 - 
 
  
BOARD REGULATION NO.2, SERIES OF 2008  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 2 , Series o f 2008 - Inclusion o f Aminptine in the List 
of Dangerous Drugs  
3 Date of Publication  14 May 2008 
4 Date of entry into force  29 May 2008 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2008/Bd.%20Reg.%2
02%2008.pdf  
 
6 Have you attached a 
copy of the regulation 
(PDF) to the Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 to 
14) 
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 and 
16) 
8 List of products subject 
to licensing  Amineptine  and any material, compound, mixture or  preparation which 
contains any quantity of AMINEPTINE, including its salts, isomers,  and salts 
of isomers within the specific chemical designation, by whatever official,  
common, unusu al or brand name or designation  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for submission of 
applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 8 9208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), 
please indicate the type 
of new change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 13 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one 
of the WTO official 
languages)   
 
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 14 - 
 
  
BOARD REGULATION NO.5, SERIES OF 2009  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 5 , Series o f 2009 - Inclusion of N -Benzylpiperazine 
(Bzp) in the List o f Dangerous Drugs  
3 Date of Publication  12 November 2009 
4 Date of entry into force  27 November 2009 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2009/BD.%20REG5%
20%2009.pdf  
 
6 Have you attached a 
copy of the regulation 
(PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 to 
14) 
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 and 
16) 
8 List of products subject 
to licensing  All raw material and preparations/mixtures containing N-Benzylpiperazine  
(BZP)  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure 
being implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative 
body(ies) for  
submission of 
applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on 
eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of 
the WTO official 
languages    
15 In the case of 7(b), 
please indicate the 
type of new change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 15 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in 
one of the WTO official 
languages)   
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 16 - 
 
  
BOARD REGULATION NO.1, SERIES OF 2010  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 1 , Series o f 2010 - Inclusion of Nalbuphine 
Hydrochloride in t he List  of Dangerous Drugs  
3 Date of Publication  16 December 2010 
4 Date of entry into force  31 December 2010 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2010/BD.REG1%20%
2010.pdf  
 
6 Have you attached a copy 
of the regulation (PDF) to 
the Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 to 
14) 
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 and 
16) 
8 List of products subject to 
licensing  Nalbuphine Hydrochloride, and the salts, isomers, and  complexes of 
Nalbuphine and their preparations  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and the 
prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for 
submission of applications   
 Ministry/authority and Department: Dangerous Drugs Board  
Address: 3F DDB PDEA Bldg. NIA Rd., Brgy. Pinyahan, Diliman, Quezon 
City, NCR, Philippines   
Website: https://pdea.gov.ph  
Telephone: (+632) 89294544 loc al 151  
E-Mail: info@ddb.gov.ph    
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  
 Product coverage;  G/LIC/ N/2/PHL/140  
 
- 17 - 
 
   Category  Notification details  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official 
languages)   
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 18 - 
 
  
BOARD REGULATION NO.2, SERIES OF 2013  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 2 , Series o f 2013 - Inclusion of Methylephedrine i n 
the List o f Dangerous Drugs  
3 Date of Publication  
 n/a 
4 Date of entry into force  
 n/a 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2013/BD.REG2%2013
.pdf 
 
6 Have you attached a copy 
of the regulation (PDF) to 
the Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 to 
14) 
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 and 
16) 
8 List of products subject 
to licensing  Methylephedrine  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) 
for 
submission of 
applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency   
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), 
please indicate the type 
of new change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 19 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one 
of the WTO official 
languages)   
 
  G/LIC/ N/2/PHL/140  
 
- 20 - 
 
  
BOARD REGULATION NO.5, SERIES OF 2016  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation  No. 5 , Series of 2016 - Inclusion o f Acetylfentanyl in 
the List o f Dangerous Drugs  
3 Date of Publication  8 November 2016 
4 Date of entry into force  23 November 2016 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.g ov.ph/images/Board_Regulation/2016/2016 -
Board_Regulation_No._5_ -
_Inclusion_of_ACETYFENTANYL_in_the_list_of_DD.pdf  
6 Have you attached a copy of 
the reg ulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[ ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 
to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  Dangerous drugs and controlled precursors and essential chemicals  
 
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and the 
prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 21 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
  G/LIC/ N/2/PHL/140  
 
- 22 - 
 
  
BOARD REGULATION NO.6, SERIES OF 2016  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board  Regulation No. 6 , Series  of 2016  - Inclusion o f 1-Cyclohexyl -
4(1,2-Diphenylethyl) Piperazine o r MT45 in the List o f Dangerous Drugs  
3 Date of Publication  8 November 2016 
4 Date of entry into force  23 November 2016 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2016/2016 -
Board_Regulation _No._6_ -_Inclusion_of_1 -CYCLOHEXYL -4-12-
DIPHENYLETHYL_PIPERAZINE_or_MT -45_in_the_list_of_DD.pdf  
6 Have you attached a copy of 
the regulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 
to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  1-Cyclohexyl -4 (1,2-Diphenyle thyl) Piperazine o r MT45 
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  
 Product coverage;  G/LIC/ N/2/PHL/140  
 
- 23 - 
 
   Category  Notification details  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
 
  G/LIC/ N/2/PHL/140  
 
- 24 - 
 
  
BOARD REGULATION NO.7, SERIES OF 2016  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 7, Series of 2016 - Inclusion o f Methoxethamine 
or MXE  in the List o f Dangerous Drugs  
3 Date of Publication  8 November 2016 
4 Date of entry into force  23 November 2016 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2016/2016 -
Board_Regulation_No._7_ -
_Inclusion__of_METHOXETAMINE_or_MXE_in_the_list_of_DD.pdf  
6 Have you attached a copy of 
the regulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 
to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  Methoxethamine o r MXE 
 
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman,  Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  
 Product coverage;  G/LIC/ N/2/PHL/140  
 
- 25 - 
 
   Category  Notification details  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 26 - 
 
  
BOARD REGULATION NO.8, SERIES OF 2016  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board  Regulation No. 8 , Series of 2016 - Inclusion o f Para-
Methoxymethamphetamine or PMMA  in the List o f Dangerous Drugs  
3 Date of Publication  8 November 2016 
4 Date of entry into force  23 November 2016 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2016/2016 -
Board_Regulation_No._8_ -_Inclu sion_of_PARA -
METHOXYMETHYLAMPHETAMINE_or_PMMA_in_the_list_of_DD.pdf  
6 Have you attached a copy of 
the regulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 
8 to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  Para-Methoxymethamphetamine or PMMA  
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman,  Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 27 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 28 - 
 
  
BOARD REGULATION NO.9, SERIES OF 2016  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board  Regulation No. 9 , Series of 2016: Inclusion o f A-
Pyrrolidinovalerophenone Or A -PYP in the List o f Dangerous Drugs  
3 Date of Publication  8 November 2016 
4 Date of entry into force  23 November 2016 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2016/2016 -
Board_Regulation_No._9_ -_Inclusi on_of_A -
PYRROLIDINOVALEROPHENONE_or_A -PVP_in_the_list_of_DD.pdf  
6 Have you attached a copy of 
the regulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 
8 to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  Dangerous drugs and controlled precursors and essential chemicals  
 
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman,  Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 29 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
 
  G/LIC/ N/2/PHL/140  
 
- 30 - 
 
  
BOARD REGULATION NO.10, SERIES OF 2016  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 10 , Series  of 2016 – Inclusion o f Para-Methyl -4-
Methylaminorex or 4,4’ -DMAR  in the List o f Dangerous Drugs  
3 Date of Publication  8 November 2016 
4 Date of entry into force  23 November 2016 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2016/2016 -
Board_Regulation_No._10_ -_Inclusion_of_PARA -METHYL -4-
METHYLAMINOREX_or_44 -DMAR_in_the_list_of_DD.pdf   
6 Have you attached a copy of 
the regulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[  ] No. 
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 
8 to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  Para-Methyl-4-Methylaminorex  or 4,4’-DMAR   
9 Nature of licensing  Automatic: [ ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman,  Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 31 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
 
 
  G/LIC/ N/2/PHL/140  
 
- 32 - 
 
  
BOARD REGULATION NO. 11, SERIES OF 2016  
 Category  Notification details  
1 Notifying Member  Philippines  
2 Title of new 
legislation/procedure  Board Regulation No. 11, Series of 2016 - Inclusion o f Phenazepam  in 
the List o f Dangerous Drugs  
3 Date of Publication  8 November 2016 
4 Date of entry into force  23 November 2016 
5 Website link/Official 
publication of the new 
regulation/procedure  https://www.ddb.gov.ph/images/Board_Regulation/2016/2016 -
Board_Regulation_No._11_ -
_Inclusion_of_PHENAZEPAM_in_the_list_of_DD.pdf  
6 Have you attached a copy of 
the regulation (PDF) to the 
Secretariat  [X] Yes. ( Please attach a copy of the regulation to the notification. ) 
 
[ ] No.  
7 Type of notification  [X] (a) New licensing regulation/procedure2; (please answer question 8 
to 14)  
 
[  ] (b) Changes to a regulation/procedure which has been previously 
notified in document: ______________; ( please answer question 15 
and 16 ) 
8 List of products subject to 
licensing  Phenazepam   
9 Nature of licensing  Automatic: [  ] 
 
Non-Automatic: [ X] 
10 Administrative 
purpose/measure being 
implemented  (a)  Protect public morals;  
(b)  Protect human, animal or plant life and health; protect 
environment;  
(c)  Collect trade statistics or market surveillance;  
(d)  Protection of patents, trademarks and copyrights, and 
the prevention of deceptive practices;  
(e)  Pursue obligations under the UN Charter and other 
international treaties ( i.e. CITES, Basel Convention, 
Rotterdam Convention, UNSC Resolutions etc.)  
(f)  Quota (including TRQ) administration;  
(g)  Regulate imports of arms, ammunition or fissionable 
materials and safeguard national security;  
(h)  Other: ______________ (please specify)  
11 Administrative body(ies) for  
submission of applications   
 Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman, Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
12 Contact point for 
information on eligibility  Ministry/authority and Department: Philippine Drug Enforcement 
Agency  
Address: PDEA Building, NIA Road, National Government Center, East 
Triangle, Diliman,  Quezon City, NCR,  Philippines  
Website: https://pdea.gov.ph  
Telephone: (+632) 89208110/ 89279702 loc al 197/198  
E-Mail: cs@pdea.gov.ph   
13 Expected duration of 
licensing procedure  Ongoing  
 
14 A summary of the 
notification in one of the 
WTO official languages    
15 In the case of 7(b), please 
indicate the type of new 
change(s)  (a)  Termination  
(b)  Suspension  
(c)  Modification of specific details in existing  
procedures:  G/LIC/ N/2/PHL/140  
 
- 33 - 
 
   Category  Notification details  
 Product coverage;  
 Administrative purpose;  
 Automatic or Non -automatic;  
 Duration of licensing;  
 Change the nature of quantity/value restriction;  
 Eligibility of applicants;  
 Contact information on eligibility;  
 Administrative body(ies) for submission of application;  
 Documentation requirements (including application form);  
 Period for Application;  
 Administrative body(ies) to issue licence;  
 Processing time for issuing licence;  
 Licence fee/administrative charge;  
 Deposit/advance payment and relevant conditions;  
 Appeal regulations/procedures;  
 Validity of licence;  
 Other conditions of licence (extension, transferability, 
penalty of non -use etc.);  
 Foreign exchange requirements;  
 Other: __________ (please specify).  
 
16  Please elaborate the 
changes in detail (in one of 
the WTO official languages)   
 
 
 
__________